CLARK ELIANA (EVP, Chief Technical Officer) sold 0.7% of their position (679.00 shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2025ACC: 0000950170-25-032263
Officer· EVP, Chief Technical Officer
Since Feb 2022
+77.03K
Net shares
Net buyer
$6.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
77.71K acquired · 679.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+32K
Price / share
—
Trade value
—
% of position
50.0%
3/1/2025
64.05K→96.05K
Common Stock
Direct
Shares
−679.00
Price / share
$8.99
Trade value
$6.10K
% of position
0.7%
3/4/2025
96.05K→95.37K
Total
Net shares
+31.32K
Net value
-$6.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | A · Award | +32K | — | — | 50.0% | 64.05K | 96.05K |
| Common Stock Direct | 3/4/2025 | S · Sale | −679.00 | $8.99 | $6.10K | 0.7% | 96.05K | 95.37K |
| Total | +31.32K | -$6.10K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
45.71K shares
Shares
+45.71K
Strike price
10.09
Held after
45.71K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock45.71K shares | 3/1/2025 | A · Award | +45.71K | 10.09 | — | 45.71K |